Table 1

Clinicopathological and immunohistochemical features of the retinoblastomas used in the study

NoAge (years)/sexClinicopathological parametersChemotherapyKAI1 immunoreactivityKi67
% Cells stainedStain intensity% cells stained
diff  =  differentiated; Postop  =  postoperative; chemo  =  chemotherapy.
12/MBoth eyes, (RE) well diffNo903+40
25/MLE, poor diffNo903+37
31/FRE, well diffNo903+63
42/MBoth eyes, (RE), well diffNo502+40
58/MLE, poor diffNo903+40
64/FLE, poor diffNo803+60
71/FLE, poor diffNo953+49
85/FRE, poor diffNo452+50
91/FBoth eyes, (RE), mod diffNo803+40
102/FBoth eyes, RE, mod diffNo853+70
112/FBoth eyes, LE, mod diffNo402+66
121.5/MRE, well diffNo853+50
137/FLE, mod diff, No choroidal invasion, surgical end of the optic nerve invadedPostop chemo 3 cycles1056
141/MRE, poor diff, Pre laminarNo201+60
152/FRE, poor diff, diffuse choroidal invasion, surgical end of optic nerve invadedPostop chemo 4 cycles1070
164/MBoth eyes, LE, poor diffPostop chemo 4 cycles1070
174/FRE, mod diff, lamina cribrosaNo402+64
182/MRE, poor diff, lamina cribrosaNo201+66
191.1 M/FRE, poor diff, diffuse choroidal invasion and post laminar optic nerve invasionPostop chemo 6 cycles1080
203/MLE, poor diff, post laminar invasionPostop chemo 2 cycles101+60
214/FRE, mod diff, focal choroidal invasionNo101+69
222/FRE, poor diff, post laminarNo0070
232.5/FRE, poor diff, diffuseNo101+60
243/MRE, poor diff, post laminarNo1070
255/MRE, poor diff, diffuse choroidal invasion, surgical end of ON invadedPostop chemo 6 cycles1060
265/FBoth eyes,(RE) well diff, pre laminar, focal choroidal invasionNo101+75
272/FBoth eyes, (LE) poor diff, diffuseNo101+60
282/MRE, poor diff, post laminarNo1080
291/FBoth eyes, (RE) well diff, lamina cribrosaPreop and postop chemo101+61
302/FPoor diff, diffuse choroidal, post laminar, metastasis to submandibular areaPostop chemo1060